Dimerix Limited (DXB.AX)
Develops kidney and lung disease treatments using a proprietary drug discovery platform
0.24-0.04%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-50.0%
The outlook
Dimerix trades at $0.24, sitting near its 52-week lows with mixed momentum against key moving averages. Analyst coverage shows a notably bullish average price target sitting roughly 690% above the current price, though overall sentiment remains neutral. The stock presents a wide disconnect between current price levels and consensus targets.
What’s behind the score
Price trendMixed vs its moving averages
52-week range16% of the way from its 52-week low to high
Price targetAvg target +690% vs current price
Market cap
$144.1M
52-wk high
0.67
52-wk low
0.16
50-day avg
0.21
200-day avg
0.39
Trailing P/E
—